-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Arrowhead Pharma, Raises Price Target to $110

Benzinga·01/13/2026 15:36:22
Listen to the news
Piper Sandler analyst Edward Tenthoff reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Overweight and raises the price target from $100 to $110.